Table 2.
Sex differences in neuropsychiatric, neurological and neurodegenerative conditions
Condition | Sex differences in prevalence | Sex differences in onset | Sex differences in phenotype | Refs |
---|---|---|---|---|
Neuropsychiatric conditions with origins in development | ||||
Autism spectrum disorder | Four to five times higher in males than in females | None | More social impairment in males; more affective symptoms in females | 87,88, 162,163 |
Conduct disorder oppositional defiance disorder | Three times higher in males than in females | Earlier onset in males | More externalizing symptoms in males; more affective symptoms in females | 164,165 |
ADHD | Two to three times higher in males than in females | None | More hyperactivity, externalizing and impulsivity in males; more internalizing, inattention and intellectual impairment in females | 166,167 |
Schizophrenia | 1.42 times higher in males than in females | Earlier onset in males than in females (early onset is more likely in males; late onset is more likely in females) | More language disruption, positive symptoms and severe course of illness in males; more affective symptoms in females | 98,99, 168–170 |
Neurological developmental conditions | ||||
Dyslexia and/or reading impairment | Two to three times higher in males than in females | None | None known | 104,105 |
Stuttering | 2.3 times higher in males than in females | Adolescent onset four times higher in males than females | None known | 103 |
Tourette syndrome | Three to four times higher in males than in females | Earlier onset in males | Greater tic severity in adulthood in females | 106 |
Adult onset neuropsychiatric conditions | ||||
Major depression | None before puberty; two times higher in females than in males post-puberty | None | None known | 171–175 |
Bipolar disorder | None for bipolar I; bipolar II higher in females than in males | Earlier onset in males | Sex by genotype interaction | 176–179 |
Generalized anxiety | Two times higher in females than in males | None | Higher chronicity and comorbidity with major depression in females | 174, 180–182 |
Panic disorder | 2.5 times higher in females than in males | None | None known | 180 |
OCD | 1.5 times higher in females than in males | None | None known | 183 |
PTSD | Two times higher in females than in males | None | More likely in females than in males following childhood trauma | 184,185 |
Anorexia nervosa | Three times higher in females than in males | Unknown | None known | 186–189 |
Bulimia | Three to four times higher in females than in males | Unknown | None known | 186–189 |
Alcoholism or substance abuse | Higher in males than in females | Earlier in females than males | Females progress to addiction more quickly than males | 190 |
Adult neurological conditions | ||||
Migraine | None pre-puberty, but three times higher in females than males post-puberty | None | None known | 191,192 |
Stroke | Higher in males than females before age 85, but higher in females than males after age 85 | Males 4 years before females | None known | 193,194 |
Neurodegenerative disease | ||||
MS (with exception of primary progressive MS) | Two times higher in females than males | Earlier onset in females | More severe in males | 195–197 |
Alzheimer disease | 1.5–2 times higher in females than males, especially in those over 80 years | Earlier onset in females | More tangles and global pathology in females; pathology more highly correlated with clinical score in females | 198–201 |
Parkinson disease | 1.5 times higher in males than females | Males 2 years before females | None known | 202 |
ALS | Three times higher in males than females | Earlier onset in males | None known | 197,203 |
Myasthenia gravis | Four times higher in females than males | Earlier onset in females | None known | 196 |
ADHD, attention deficit hyperactivity disorder; ALS, amyotrophic lateral sclerosis; Bipolar I, bipolar spectrum disorder characterized by at least one manic or mixed episode; Bipolar II, bipolar spectrum disorder characterized by at least one episode of major depression lasting two or more weeks and at least one hypomanic episode; MS, multiple sclerosis; OCD, obsessive compulsive disorder; PTSD, post-traumatic stress disorder.